On Tuesday, Cellebrite DI Ltd (NASDAQ: CLBT) was -2.11% drop from the session before settling in for the closing price of $16.62. A 52-week range for CLBT has been $10.55 – $26.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Technology sector has jumped its sales by 19.78% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 125.17%. With a float of $108.96 million, this company’s outstanding shares have now reached $239.47 million.
In an organization with 1167 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.06%, operating margin of 14.3%, and the pretax margin is -44.69%.
Cellebrite DI Ltd (CLBT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cellebrite DI Ltd stocks. The insider ownership of Cellebrite DI Ltd is 54.50%, while institutional ownership is 37.05%. The most recent insider transaction that took place on May 23 ’25, was worth 203,026. Before that another transaction happened on May 21 ’25, when Company’s OFFICER proposed sale 10,555 for $17.05, making the entire transaction worth $179,963.
Cellebrite DI Ltd (CLBT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 125.17% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
You can see what Cellebrite DI Ltd (CLBT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.29. Likewise, its price to free cash flow for the trailing twelve months is 29.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 0.39 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.59 million. That was inferior than the volume of 1.6 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 27.98%. Additionally, its Average True Range was 0.64.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 1.76%, which indicates a significant decrease from 12.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.77% in the past 14 days, which was lower than the 48.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.34, while its 200-day Moving Average is $19.25.
